Polypills for HFrEF are being tested in RCTs, and if they’re approved, experts want to be ready for their rollout and use.

There’s a need in secondary prevention for personalized risk estimates to motivate patients and guide care, researchers say.

Researchers support limiting these surgeries to centers that do the most cases, though true high-volume hospitals remain rare ...

Doctors might feel out of their element making the videos, but patients respond to the short, informative reels.

Data from implantable monitors show a low AF burden with time, leading some to question the need for oral anticoagulation.

Even limited use of veins appears to diminish the long-term benefits of an all-arterial approach,” says Alistair Royse.

Large-bore devices and longer time on support each up the risk. A study author calls for awareness, not alarm.